Catalyst Pharmaceutical Inc (NASDAQ: CPRX) stock closed at $14.57 on 1/5/24 after a major decline of -14.8%. Moreover, exceptionally high trading volume at 570% of normal accompanied the decline. The stock has been strong relative to the market over the last nine months but has declined -15.7% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, CPRX is expected to continue to be a major Value Builder.
Catalyst Pharmaceutical has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Catalyst Pharmaceutical has a slightly positive Power Rating of 62 and a very high Appreciation Score of 97, and the Highest Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment